The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activtiy is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. The CDK4 activity associated with this cyclin was reported to be necessary for cell cycle progression through G2 phase into mitosis after UV radiation.[1]
Motokura T, Keyomarsi K, Kronenberg HM, Arnold A (1992). "Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene". J. Biol. Chem. 267 (28): 20412–5. PMID1383201.CS1 maint: Multiple names: authors list (link)
Inaba T, Matsushime H, Valentine M; et al. (1992). "Genomic organization, chromosomal localization, and independent expression of human cyclin D genes". Genomics. 13 (3): 565–74. PMID1386335.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Xiong Y, Menninger J, Beach D, Ward DC (1992). "Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins". Genomics. 13 (3): 575–84. PMID1386336.CS1 maint: Multiple names: authors list (link)
Motokura T, Yi HF, Kronenberg HM; et al. (1992). "Assignment of the human cyclin D3 gene (CCND3) to chromosome 6p----q13". Cytogenet. Cell Genet. 61 (1): 5–7. PMID1387066.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Matsuoka S, Yamaguchi M, Matsukage A (1994). "D-type cyclin-binding regions of proliferating cell nuclear antigen". J. Biol. Chem. 269 (15): 11030–6. PMID7908906.CS1 maint: Multiple names: authors list (link)
Meyerson M, Harlow E (1994). "Identification of G1 kinase activity for cdk6, a novel cyclin D partner". Mol. Cell. Biol. 14 (3): 2077–86. PMID8114739.
Dowdy SF, Hinds PW, Louie K; et al. (1993). "Physical interaction of the retinoblastoma protein with human D cyclins". Cell. 73 (3): 499–511. PMID8490963.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Brooks AR, Shiffman D, Chan CS; et al. (1996). "Functional analysis of the human cyclin D2 and cyclin D3 promoters". J. Biol. Chem. 271 (15): 9090–9. PMID8621559.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Tiefenbrun N, Melamed D, Levy N; et al. (1996). "Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest". Mol. Cell. Biol. 16 (7): 3934–44. PMID8668211.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Hirai H, Sherr CJ (1996). "Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1". Mol. Cell. Biol. 16 (11): 6457–67. PMID8887674.
Gómez Lahoz E, Liegeois NJ, Zhang P; et al. (1999). "Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo". Mol. Cell. Biol. 19 (1): 353–63. PMID9858559.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Gabrielli BG, Sarcevic B, Sinnamon J; et al. (1999). "A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay". J. Biol. Chem. 274 (20): 13961–9. PMID10318807.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Zhang Q, Wang X, Wolgemuth DJ (1999). "Developmentally regulated expression of cyclin D3 and its potential in vivo interacting proteins during murine gametogenesis". Endocrinology. 140 (6): 2790–800. PMID10342870.CS1 maint: Multiple names: authors list (link)
Bartkova J, Rajpert-de Meyts E, Skakkebaek NE, Bartek J (2000). "D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy". J. Pathol. 187 (5): 573–81. doi:10.1002/(SICI)1096-9896(199904)187:5<573::AID-PATH289>3.0.CO;2-H. PMID10398124.CS1 maint: Multiple names: authors list (link)
Jones CJ, Kipling D, Morris M; et al. (2000). "Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells". Mol. Cell. Biol. 20 (15): 5690–9. PMID10891505.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Sansal I, Dupont E, Toru D; et al. (2000). "NPDC-1, a regulator of neural cell proliferation and differentiation, interacts with E2F-1, reduces its binding to DNA and modulates its transcriptional activity". Oncogene. 19 (43): 5000–9. doi:10.1038/sj.onc.1203843. PMID11042687.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Fink JR, LeBien TW (2001). "Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors". Exp. Hematol. 29 (4): 490–8. PMID11301189.
Lin J, Jinno S, Okayama H (2001). "Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence". Oncogene. 20 (16): 2000–9. doi:10.1038/sj.onc.1204375. PMID11360184.CS1 maint: Multiple names: authors list (link)
Bartkova J, Thullberg M, Slezak P; et al. (2001). "Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon". Gastroenterology. 120 (7): 1680–8. PMID11375949.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)